Biota to Present at the Jefferies 2014 Global Healthcare Conference
May 28 2014 - 09:58AM
Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today
announced that its Executive Vice President, Dr. Joseph Patti, will
present a corporate update at the Jefferies 2014 Global Healthcare
Conference on Monday, June 2nd at 8:00 AM ET at The Grand Hyatt
Hotel in New York City.
The presentation will be webcast live and may be accessed
through the Investor Relations' Events and Presentations section on
Biota's website at www.biotapharma.com. Please go to the website at
least 15 minutes prior to the event to register, download and
install any necessary audio/video software. An archived replay will
also be available for 30 days following the live presentation.
About Biota
Biota Pharmaceuticals, Inc. is a biopharmaceutical company
focused on the discovery and development of products to prevent and
treat serious and potentially life-threatening infectious diseases.
The Company currently has two Phase 2 clinical-stage product
candidates: laninamivir octanoate, which the Company is developing
for the treatment of influenza A and B infections under an IND in
the United States; and vapendavir, a potent, oral broad spectrum
capsid inhibitor of enteroviruses, including human rhinovirus. In
addition to these clinical-stage development programs, the Company
has preclinical programs focused on developing treatments for
respiratory syncytial virus. For additional information about the
Company, please visit www.biotapharma.com.
Biota is a registered trademark of Biota Pharmaceuticals,
Inc.
CONTACT: Russell H. Plumb
Chief Executive Officer
(678) 221-3351
r.plumb@biotapharma.com
Lee M. Stern
The Trout Group
(646) 378-2922
lstern@troutgroup.com
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Mar 2023 to Mar 2024